Who makes Contrave and Counseling?

Contrave and Counseling is developed by University of Nebraska.

What development phase is Contrave and Counseling in?

Contrave and Counseling is FDA-approved (marketed).

Last reviewed 2026-05-15 · How we verify

Contrave and Counseling

University of Nebraska · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Contrave and Counseling
Also known as	motivational interviewing and pharmaceutical
Sponsor	University of Nebraska
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) (PHASE2, PHASE3)
Pharmacological and Behavioral Treatment After Bariatric Surgery (PHASE2, PHASE3)
Assessment of and Treatment Applied to Food Addiction in a Rural Healthy Behaviors Clinic (PHASE4)
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment (PHASE2, PHASE3)
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study) (PHASE3)
A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Contrave and Counseling CI brief — competitive landscape report
Contrave and Counseling updates RSS · CI watch RSS
University of Nebraska portfolio CI